Trails Center.org

Clinical Trial Name -Study Evaluating the Effect of Lecozotan SR on the QTc Interval

 
Original Study ID : 3098B1-133
NCT ID : NCT00499642
Brief Title : Study Evaluating the Effect of Lecozotan SR on the QTc Interval
Official Title : A Single-Dose, Double-Blind, Crossover, Placebo- and Moxifloxacin (Open-Label)-Controlled Study of the Effects of Lecozotan SR on Cardiac Repolarization in Healthy Adult Subjects
Brief Summary : This is a randomized, double-blind, placebo- and moxifloxacin (open-label)-controlled, 4-period crossover study.
Source : Wyeth
Overall Status : Completed
Start Date : June 2007
End Date : August 2007
Completion Date : August 2007
Official Title : Phase 1
Phase : Interventional
Study Design : Treatment, Randomized, Double-Blind, Active Control, Crossover Assignment
Verification Date : December 2007
First Received Date : July 10, 2007
Trial Eligibility
Criteria :
Inclusion Criteria:

- Women and men aged 18 to 55 years inclusive.

- Healthy as determined by the investigator on the basis of medical history, physical
examination, clinical laboratory test results, vital signs, and 12-lead
electrocardiogram (ECG).

Exclusion Criteria:

- History of any clinically important drug allergy.

- Positive findings of urine drug screen (eg, amphetamines, barbiturates,
benzodiazepines, cannabinoids, cocaine, and opiates).
Gender : Both
Minimum Age : 18 Years
Maximum Age : 55 Years
Healthy Volunteers : Accepts He
Facilities
City : Rennes
Zip Code : 35000
Country : France
City : Rueil-Malmaison
Zip Code : 92502
Country : France
 
Search Trials By
Search
 
Research
 
 
Most Popular Trials
 
Library
 
Discuss
 
Recent Topics
Kill The Belly Fat ...
The belly Fat Assassin All unhealthy fat is unpleasant. I might as ...
Here Are Particular ...
Losing extra pounds could be a challenge that faces many people ...
Stop Tooth Abscess ...
Stop Tooth Abscess Pain - Disinfectant Spray With an abscess tooth, ...